U
Ulla Puistola
Researcher at Oulu University Hospital
Publications - 82
Citations - 2757
Ulla Puistola is an academic researcher from Oulu University Hospital. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 34, co-authored 79 publications receiving 2607 citations. Previous affiliations of Ulla Puistola include University of Oulu.
Papers
More filters
Journal ArticleDOI
L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
Alain G. Zeimet,Daniel Reimer,Monica Huszar,Boris Winterhoff,Ulla Puistola,Samira Abdel Azim,Elisabeth Müller-Holzner,Alon Ben-Arie,Léon C van Kempen,Edgar Petru,Stephan W Jahn,Yvette P. Geels,Leon F.A.G. Massuger,Frédéric Amant,Stephan Polterauer,Elisa Lappi-Blanco,Johan Bulten,Alexandra Meuter,Staci Tanouye,Peter Oppelt,Monika Stroh-Weigert,Alexander Reinthaller,Andrea Mariani,Werner O. Hackl,Michael Netzer,Uwe Schirmer,Ignace Vergote,Peter Altevogt,Christian Marth,Mina Fogel +29 more
TL;DR: L1CAM has been shown to be the best-ever published prognostic factor in FIGO stage I, type I endometrial cancers and shows clear superiority over the standardly used multifactor risk score.
Journal ArticleDOI
8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
TL;DR: Low serum 8-oxodG levels and a low immunohistochemical 8- oxodG expression were associated with an aggressive breast cancer phenotype and negative 8-OxodG immunostaining was a powerful prognostic factor for breast cancer-specific death in breast carcinoma patients.
Journal ArticleDOI
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
Piritta Hynninen,L Vaskivuo,Juha Saarnio,Hannu Haapasalo,Jyrki Kivelä,Silvia Pastorekova,Jaromir Pastorek,Abdul Waheed,William S. Sly,Ulla Puistola,Seppo Parkkila,Seppo Parkkila +11 more
TL;DR: The aim of the present study was to investigate CA IX and XII expression in patients with ovarian tumours and to investigate the role of these molecules in oncogenic processes.
Journal ArticleDOI
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer—MMP-9 correlates to the grade and the stage
Kristina Aglund,Marita Rauvala,Ulla Puistola,Tord Ångström,Taina Turpeenniemi-Hujanen,Björn Zackrisson,Ulf Stendahl +6 more
TL;DR: MMP-2 and MMP-9 could serve as markers for the clinical behavior of endometrial cancer and may turn out to be potentially useful in decision making about the need for an adjuvant treatment.
Journal ArticleDOI
Evidence of Founder Mutations in Finnish BRCA1 and BRCA2 Families
Pia Huusko,Kati Pääkkönen,Virpi Launonen,Minna Pöyhönen,Guillermo Blanco,Antti Kauppila,Ulla Puistola,Heikki Kiviniemi,Marika Kujala,Jaakko Leisti,Robert Winqvist +10 more
TL;DR: This study was supported by the University of Oulu, Oulu University Hospital, the Finnish Cancer Society, the Cancer Foundation of Northern Finland, and the Finnish Breast Cancer Group.